𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Structural basis of inhibition of cysteine proteases by E-64 and its derivatives

✍ Scribed by Keita Matsumoto; Kazutoshi Mizoue; Kunihiro Kitamura; Wai-Ching Tse; Carol P. Huber; Toshimasa Ishida


Publisher
Wiley (John Wiley & Sons)
Year
1999
Tongue
English
Weight
466 KB
Volume
51
Category
Article
ISSN
0006-3525

No coin nor oath required. For personal study only.

✦ Synopsis


This paper focuses on the inhibitory mechanism of E-64 and its derivatives (epoxysuccinyl-based inhibitors) with some cysteine proteases, based on the binding modes observed in the x-ray crystal structures of their enzyme-inhibitor complexes. E-64 is a potent irreversible inhibitor against general cysteine proteases, and its binding modes with papain, actinidin, cathepsin L, and cathepsin K have been reviewed at the atomic level. E-64 interacts with the S n subsites of cysteine proteases. Although the S n -P n (n ϭ 1 ϳ 3) interactions of the inhibitor with the main chains of the active site residues are similar in respective complexes, the significant difference is observed in the side-chain interactions of S 2 -P 2 and S 3 -P 3 pairs because of different residues constituting the respective subsites. E-64-c and CA074 are representative derivatives developed from E-64 as a clinical usable and a cathepsin B-specific inhibitors, respectively.


📜 SIMILAR VOLUMES


Inhibition of polyphenoloxidase activity
✍ Sophie Chériot; Catherine Billaud; Marie-Noëlle Maillard; Jacques Nicolas 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB

## Abstract It had previously been shown that soluble Maillard reaction products (MRP) made from thiol compounds and glucose or fructose contained powerful inhibitors of various fruit and vegetable polyphenoloxidase (PPO) activity. In MRP from cysteine and glucose, the amount of hydroxymethylfurfur

Inhibition of neurotransmitter receptor
✍ Robert E. Hruska; Ellen K. Silbergeld 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

## Abstract Bromocriptine, lergotrile, lisuride, metergoline, and the Sandoz ergot derivatives 25–397, 29–712, and 29–717 have been tested for their ability to inhibit the synaptic receptor binding of spiroperidol, 5‐hydroxytryptamine (5‐HT), d‐lysergic acid diethylamide (LSD), quinuclidinyl benzil